Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MHRA

Diabetes drug authorised for weight management and loss – MHRA

Obese and overweight adults could have access to Tirzepatide – also known as Mounjaro – if it receives further approval.

The Independent UK

Private health firm Sciensus fails to fix defects that led to UK patient’s death

Exclusive: Regulator extends part suspension of licence to July 2024 after IT blunder led to incorrect dosage of cancer treatment

The Guardian - UK

Functional fungi: can medicinal mushrooms really improve people’s health?

The boom in sales of mushroom products has led to many claims for their wellbeing and curative properties, but is there any scientific evidence to back them up?

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Urgent warning over counterfeit Ozempic after hospitalisations

Medicines regulator seizes 369 potentially fake devices amid surge in demand

Evening Standard

Warning as patients hospitalised after taking fake Ozempic weight-loss drug

Hundreds of fake Ozempic jabs from the black market have been seied by the regulator

The Independent UK

UK public warned over dangers of fake weight loss medication pens

Pre-filled injection devices claimed to hold Ozempic or Saxenda may contain other substances, regulator says

The Guardian - UK

Taking cholesterol-reducing pills? Serious side effects you need to know

Last week, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) had released a report stating that "there have been some suspected reports of new-onset or aggravation of pre-existing myasthenia gravis or ocular myasthenia associated with statin use." Myasthenia gravis is an autoimmune neuromuscular disorder that is characterised by fluctuating…

The Times of India

Read news from The Economist, FT, and more,
with one subscription

‘These patients do not have time’: families in UK demand access to new drug that slows brain tumours

Vorasidenib worked in trials but is not yet available on the NHS

The Guardian - UK

‘I didn’t want to be here anymore’: The agony of women suffering with topical steroid withdrawal

The condition is caused after the repeated use of steroid creams and tablets commonly prescribed by the NHS, Holly Evans writes

The Independent UK

Patients in England will be first to access seven-minute cancer treatment jab

NHS is first health system to offer injection to hundreds of patients which will cut treatment times by up to three quarters

The Guardian - UK

Public bodies named and shamed over Freedom of Information request failings

The Information Commissioner’s Office urged organisations to ensure their performance and processes complied with the law.

The Independent UK

Why life-threatening allergic reactions are on the rise

Hospital admissions for life-threatening allergic reactions have increased from 12,361 in 2002-03 to 25,721 in the past year, latest NHS figures show.

The Week

Men sentenced for selling unauthorised Covid-19 tests during pandemic

Ron Huss-Smickler, 41 from Birmingham, and Steven Lawrence Beckford, 39 from Edgbaston, bought the non-certified coronavirus tests from Alibaba.

The Independent UK

Hospital admissions for life-threatening allergies more than double in England

Number of people taken to hospital increased to 25,721 in 2022-23, from 12,361 two decades before

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Hospital admissions for life-threatening allergic reactions ‘more than double’

Data obtained by drugs regulator the MHRA shows there were 25,721 admissions to England’s hospitals for allergies and anaphylaxis in 2022/23.

The Guardian - UK

Weight-loss drugs under review in UK after reports of suicidal thoughts

Ozempic and Saxenda among drugs being reviewed after five reports of suspected adverse reactions in patients

The Guardian - UK

Sciensus’s licence partly suspended after death of cancer patient

Regulator acts after firm paid millions by NHS for healthcare gave patients wrong chemotherapy dose

Evening Standard

Codeine cough syrup: Why is it being banned in UK pharmacies?

Abusing the medical mixture has prompted a ban on UK sales

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Cough syrups could be made prescription-only over addiction fears

UK medicines safety regulator says codeine linctus could have serious health condequences

The Guardian - UK

RSV vaccine for older adults approved by UK medicines regulator

Arexvy could help NHS deal with virus that causes about 8,000 deaths among older people in UK each year

Wales Online

Investigation into risk of suicidal and self-harm thoughts among users of Wegovy, Saxenda and other weight loss jabs

It will also look at one used to for type 2 diabetes

The Independent UK

Drug regulator investigating suicidal thoughts among some weight-loss jab users

The European Medicines Agency is looking at Wegovy (semaglutide), Saxenda (liraglutide) and other similar drugs used to control appetite.

The Independent UK

Three cases of suicidal and self-harm thoughts identified in Iceland, regulator says

Daily Mirror

Cancer patient dies and 4 hospitalised after being given 'unlicensed' chemotherapy drug

The patient, who has not been named, was one of four people given an unlicensed version of prostate cancer medicine cabazitaxel, and authorities are now investigating

The Guardian - UK

Patient dies and three hospitalised in Sciensus chemotherapy incident

Exclusive: Regulators investigate after patients received unlicensed treatment from firm paid millions by NHS

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Environment Agency

Liverpool City Council

European Medicines Agency

76 stories

Tower Hamlets Council

38 stories

Allergy UK

25 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Freedom of Information Act

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.